Rancho News

  • Exciting News from Rancho BioSciences! We’re thrilled to announce our participation at The 19th Annual Huntington’s Disease Therapeutics Conference! Our team presented 3 groundbreaking posters, contributing to the vital discussions on drug discovery & development. Together, we’re pushing boundaries in Huntington’s Disease research!

  • Rancho is excited to be attending the 23rd Annual Bio IT World Conference & Expo in Boston, MA, April 15th - 17th, 2024. Please come and say Hi to us at Booth# 609.

BioIT World 2024
  • Rancho BioSciences is attending the upcoming SOT 63rd Annual Meeting in Salt Lake City, Utah March 10th – 14th. Please visit us at Booth 1704.

SOT Meeting
  • Rancho will be at The Festival of Genomics & Biodata in London, January 24th - 25th. Please come by Booth 68 and visit us!

FOG-2024
Pistoia Webinar
  • Harmonizing disease phenotypes to support genetic analysis:

    Please join Rancho’s joint webinar with Takeda on Harmonizing Disease Phenotypes to Support Genetic Analysis.

    Date: October 11, 2023 Time: 10:00 am PT / 1:00 pm ET

    Register Here: https://lnkd.in/egZH2BJW

GW-Rancho-650x200-10-11-23
  • Rancho was proud to participate in the Crohn's & Colitis Take Steps walk in June. Not only was this for a great cause, we also had a great time!

    28 Rancher’s Raised: $6,093
    Rancho Donated: $5,000
    Total Donated: $11,093

    • Top 3 Raisers: Maryann Whitley, Kevin Blighe, Joseph Ramirez

    • Ranchers that raised $150 or more: Maryann Whitley, Kevin Blighe, Joseph Ramirez, Jon Greene, Julie Bryant, Cindy Grondin

CCF-Photo-Collage
  • Rancho will be attending The Festival of Genomics & Biodata Boston October 4 – 5, 2023. We hope to see you there!

Festival of Genomics Oct 4 - 5 Boston logo
  • Rancho is thrilled to be going to Basel, Switzerland to attend the BioTechX Europe conference October 4th – 6th, 2023.

BioTechX Europe-257e7cf
  • Please come visit Rancho in Boston November 14 – 15, 2023 at the Pistoia Alliance Conference.

PIstoia Conference Nov 14 - 15 logo
  • Julie Bryant has been recognized as one of The Top 50 Women Leaders of San Diego for 2022.

    Julie Bryant is Chief Executive Officer and Founder of Rancho BioSciences, on a mission to save lives through data. Rancho BioSciences is an international fee for service data curation company with analysis and developer services. Their customers include pharma, foundations, government, and biotech companies. Rancho BioSciences is celebrating its 10-year anniversary and is experiencing exponential growth. Their strong culture code attracts the best scientists and developers that want to make a difference.

    ​Over the years Bryant has built strong teams in GeneGo and later sold to Thomson Reuters. She was also involved in the acquisition of FreedomVoice by GoDaddy. She is on the advisory board of Rady Children's Hospital and the Brain Trust Committee at John Wayne Cancer Institute. Bryant is a graduate of Coventry University.
    ​https://thewomenweadmire.com/2022/04/25/the-top-50-women-leaders-of-san-diego-for-2022/

Julie-PhoenixHeadshots-PROOFS
  • The CHDI/Rancho publication is available as preprint

    https://pubmed.ncbi.nlm.nih.gov/34397420/

    This publication is the culmination of many years of work by Rancho curators, bioinformaticians, and developers. The Rancho team helped develop the HDinHD Explorer tool that brings together a variety of experimental data related to Huntington disease (HD) research. In addition, Rancho was responsible for creating content for the tool by curating experimental information from thousands of publications and internal CHDI reports, as well as analyzing hundreds of public datasets.​

    *Abstract*​

    HDinHD (Huntington's Disease in High Definition; HDinHD.org) is an open online portal for the HD research community that presents a synthesized view of HD-related scientific data. Here, we present a broad overview of HDinHD and highlight the newly launched HDinHD Explorer tool that enables researchers to discover and explore a wide range of diverse yet interconnected HD-related data. We demonstrate the utility of HDinHD Explorer through data mining of a single collection of newly released in vivo therapeutic intervention study reports alongside previously published reports.​

    *Rancho Authors*​

    Viktoria Andreeva, Irina Murasheva, Anastasia Shneyderman, Kabenla Armah, Rob Gill

HD-in-HD-picture-for-website (1)
GSK-Webinar-website-picture
CDK-image_1625147313341
210633_G-SRS